KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Staar Surgical (STAA) Equity Average (2016 - 2026)

Staar Surgical's Equity Average history spans 16 years, with the latest figure at $349.0 million for Q1 2026.

  • For Q1 2026, Equity Average fell 15.45% year-over-year to $349.0 million; the TTM value through Jan 2026 reached $349.0 million, down 15.45%, while the annual FY2026 figure was $370.8 million, 5.33% down from the prior year.
  • Equity Average reached $349.0 million in Q1 2026 per STAA's latest filing, up from $345.2 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $418.6 million in Q3 2024 to a low of $268.9 million in Q2 2022.
  • Average Equity Average over 5 years is $354.6 million, with a median of $349.6 million recorded in 2023.
  • Peak YoY movement for Equity Average: skyrocketed 30.75% in 2022, then decreased 17.54% in 2025.
  • A 5-year view of Equity Average shows it stood at $329.6 million in 2022, then rose by 15.97% to $382.3 million in 2023, then increased by 7.97% to $412.7 million in 2024, then decreased by 16.37% to $345.2 million in 2025, then grew by 1.1% to $349.0 million in 2026.
  • Per Business Quant, the three most recent readings for STAA's Equity Average are $349.0 million (Q1 2026), $345.2 million (Q3 2025), and $343.3 million (Q2 2025).